This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): SER140
Description: SER140 is an interleukin-1 (IL-1) receptor antagonist which inhibits liberation of TNFa in cells stimulated in an inflammatory cascade.
Additional information available to subscribers only: